ANALYSIS: Investors have lost millions and companies have collapsed, but medicinal cannabis players still see a bright future.
Shoeshine talks to an investor group that lost millions.
Legalising cannabis will put the onus on employers to prove how much weed is too much.
The NZX-listed company is up for its sixth reinvention since being founded in 1983.
The hi-tech firm stands on the brink of a 5G boom, but investors have heard it all before.
The fast food chain has to take a risk if it wants to hit its $1b revenue target.
The former peer-to-peer lender may soon be offering mums and dads another way in.
The company has to assess a regulatory price reset and duty-free bid by 2022.
Let’s hope Covid-hit SMEs can access the government assistance this time around.
Are schemes of arrangement still fit for purpose?